Practice Parameter: Corticosteroid treatment of Duchenne dystrophy [RETIRED]
Top Cited Papers
Open Access
- 11 January 2005
- journal article
- guideline
- Published by Wolters Kluwer Health in Neurology
- Vol. 64 (1) , 13-20
- https://doi.org/10.1212/01.wnl.0000148485.00049.b7
Abstract
Background: The Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society develop practice parameters as strategies for patient management based on analysis of evidence.Keywords
This publication has 42 references indexed in Scilit:
- Early prednisone treatment in Duchenne muscular dystrophyMuscle & Nerve, 2002
- Eosinophilia of Dystrophin-Deficient Muscle Is Promoted by Perforin-Mediated Cytotoxicity by T Cell EffectorsThe American Journal of Pathology, 2000
- Calcium influx inhibition by steroids and analogs in C2C12 skeletal muscle cellsBritish Journal of Pharmacology, 1998
- DeflazacortDrugs, 1995
- Low-dose prednisolone treatment in Duchenne and Becker muscular dystrophyNeuromuscular Disorders, 1995
- Deflazacort in Duchenne dystrophy: Study of long‐term effectMuscle & Nerve, 1994
- Steroids in duchenne muscular dystrophy — Deflazacort trialNeuromuscular Disorders, 1991
- Randomized, Double-Blind Six-Month Trial of Prednisone in Duchenne's Muscular DystrophyNew England Journal of Medicine, 1989
- Clinical investigation in duchenne dystrophy: 2. Determination of the “power” of therapeutic trials based on the natural historyMuscle & Nerve, 1983
- PREDNISONE IN DUCHENNE MUSCULAR DYSTROPHYThe Lancet, 1974